http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1140200-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a94563ea41975bf2436137b0a043cbc
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C225-36
filingDate 1999-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2002-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31da4234b1301a64fc69659569355a99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56eeca3c1c07ef7c0faea006527eb0d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a6dc7b6708c6303ee58cf03dca12760
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3627afb7fd1769eef38d05a628dce9e
publicationDate 2002-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1140200-B1
titleOfInvention Anthraquinone anticancer drugs
abstract A molecule of formula (I);wherein:X is a halogen, or a substituted sulfonate group;m=1-5;n=1-5;R1, R2=H, C1-4 lower alkyl or C1-4 lower alkyl chain having additional functionality; andthe amino group -NR1R2 linked to the anthraquinone is primary, secondary or tertiary or is a tertiary group in the N-oxide form having the formula -N(O)R1R2.
priorityDate 1998-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128108743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127696539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393271
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127739541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128397534
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID98535
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20267333
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395292
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127706167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135789409
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226443623
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226445593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128876649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129535494
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226818353
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6925
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66053

Total number of triples: 55.